We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$70.7B
AUM Growth
-$13.8B
Cap. Flow
-$8.71B
Cap. Flow %
-12.32%
Top 10 Hldgs %
10.57%
Holding
4,619
New
441
Increased
1,316
Reduced
2,164
Closed
637

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$578M
2
MU icon
Micron Technology
MU
+$433M
3
AMD icon
Advanced Micro Devices
AMD
+$404M
4
AMZN icon
Amazon
AMZN
+$398M
5
ACN icon
Accenture
ACN
+$358M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$777M
2
META icon
Meta Platforms (Facebook)
META
+$752M
3
TSLA icon
Tesla
TSLA
+$627M
4
CVX icon
Chevron
CVX
+$528M
5
SHOP icon
Shopify
SHOP
+$439M

Sector Composition

Rank Sector Weight
1 Healthcare 19.4%
2 Technology 18.51%
3 Consumer Staples 10.15%
4 Consumer Discretionary 9.67%
5 Financials 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLAP
3701
DELISTED
Terran Orbital Corporation
LLAP
$64K ﹤0.01%
+36,200
New +$147K
BLRX
3702
BioLineRX
BLRX
$11.8M
$63K ﹤0.01%
1,706
+562
+49% +$32.1K
VLN icon
3703
Valens Semiconductor
VLN
$210M
$62K ﹤0.01%
14,900
-93,000
-86% -$372K
XBIO icon
3704
Xenetic Biosciences
XBIO
$7.54M
$62K ﹤0.01%
11,510
-3,596
-24% -$28.4K
CAPR icon
3705
Capricor Therapeutics
CAPR
$244M
$61K ﹤0.01%
+10,200
New +$52.2K
OCUL icon
3706
Ocular Therapeutix
OCUL
$2.22B
$61K ﹤0.01%
14,793
-366,707
-96% -$1.85M
OTLK icon
3707
Outlook Therapeutics
OTLK
$166M
$61K ﹤0.01%
2,515
-8,055
-76% -$187K
CWBR
3708
DELISTED
CohBar, Inc. Common Stock
CWBR
$61K ﹤0.01%
21,123
-18,667
-47% -$93.5K
STSA
3709
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$60K ﹤0.01%
+10,000
New +$56.7K
BIVI icon
3710
BioVie
BIVI
$11.8M
$59K ﹤0.01%
235
+75
+47% +$17.8K
CLRB icon
3711
Cellectar Biosciences
CLRB
$19.8M
$59K ﹤0.01%
590
+35
+6% +$5.03K
WDH
3712
Waterdrop
WDH
$359M
$59K ﹤0.01%
54,100
-20,100
-27% -$24.4K
BPTH
3713
DELISTED
Bio-Path Holdings Inc
BPTH
$59K ﹤0.01%
930
+30
+3% +$2.28K
AHPI
3714
DELISTED
Allied Healthcare Products
AHPI
$59K ﹤0.01%
44,300
-16,300
-27% -$29.9K
BXRX
3715
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$59K ﹤0.01%
6,038
-1,974
-25% -$45.9K
IRS
3716
IRSA Inversiones y Representaciones
IRS
$1.25B
$58K ﹤0.01%
+13,731
New +$56.4K
PSNY icon
3717
Polestar Automotive Holding UK
PSNY
$2B
$58K ﹤0.01%
+380
New +$95.6K
TEO icon
3718
Telecom Argentina
TEO
$5.75B
$58K ﹤0.01%
14,500
-63,393
-81% -$278K
THRN
3719
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$58K ﹤0.01%
12,300
-34,500
-74% -$173K
PTE
3720
DELISTED
PolarityTE, Inc. Common Stock
PTE
$58K ﹤0.01%
67,222
+23,900
+55% +$29.1K
TIRX
3721
DELISTED
Tian Ruixiang Holdings
TIRX
$57K ﹤0.01%
735
-28
-4% -$2.63K
VRME icon
3722
VerifyMe
VRME
$9.06M
$57K ﹤0.01%
+44,400
New +$71K
AMBO
3723
Ambow Education Holding
AMBO
$6.06M
$56K ﹤0.01%
17,934
-830
-4% -$3.26K
ITRM
3724
DELISTED
Iterum Therapeutics
ITRM
$56K ﹤0.01%
34,684
+13,131
+61% +$39.8K
LGMK
3725
DELISTED
LogicMark
LGMK
$56K ﹤0.01%
149
+71
+91% +$39.9K
147 148
149
150 151

Similar funds

Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Jim Simons's Q3 2022 Portfolio in Review

As of Q3 2022, Jim Simons held 4,619 positions worth $70.7B, down 16% from $84.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Jim Simons withdrew a net $8.71B in Q3 2022, closing 637 positions and reducing 2,164 holdings. Its most notable exit was Shopify, an estimated $439M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Jim Simons opened a new position in Alphabet (Google) Class A worth $498M.

  • Jim Simons's largest Q3 2022 buy was Alphabet (Google) Class A: 5,208,460 shares worth $498M.
  • Jim Simons added most to Advanced Micro Devices in Q3 2022, an estimated $404M increase.
  • Jim Simons's biggest Q3 2022 reduction was Apple, cutting an estimated $777M.
  • Jim Simons fully exited Shopify in Q3 2022, selling an estimated $439M.
  • Jim Simons's ten largest holdings make up 11% of its $70.7B portfolio in Q3 2022.
  • Jim Simons opened 441 new positions and closed 637 in Q3 2022.
  • Jim Simons's portfolio value fell 16% quarter-over-quarter to $70.7B.

Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.